{"id":789927,"date":"2023-10-12T09:55:24","date_gmt":"2023-10-12T13:55:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/"},"modified":"2023-10-12T09:55:24","modified_gmt":"2023-10-12T13:55:24","slug":"precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/","title":{"rendered":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress"},"content":{"rendered":"

<\/p>\n

Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th<\/sup> Annual Congress<\/b><\/p>\n

DURHAM, N.C.–(BUSINESS WIRE<\/a>)–
\nPrecision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS\u00ae<\/sup> platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that two abstracts have been accepted by the European Society of Gene & Cell Therapy (ESGCT) for poster presentations at the upcoming Congress on October 24-27, 2023, in Brussels, Belgium.<\/p>\n

Presentation Details:<\/span><\/b><\/p>\n

Title:<\/b> Unique features of ARCUS nucleases enable high efficiency, targeted gene insertion in vivo
\n
Poster Number: <\/b>#P641
\n
Presenter: <\/b>Cassie Gorsuch, VP of Gene Therapy, Precision Biosciences
\n
Date and Time:<\/b> Wednesday, October 25, 2023, 5:00 PM – 6:15 PM CEST and Thursday, October 26, 2023, 8:30 PM – 9:30 PM CEST
\n
Location: <\/b>Gare Maritime<\/p>\n

Title:<\/b> ARCUS-mediated excision of the \u201chot spot\u201d region of the human dystrophin gene results in functional improvement in a mouse model of Duchenne muscular dystrophy (DMD)
\n
Poster Number: <\/b>Poster #P653
\n
Presenter: <\/b>Cassie Gorsuch, VP of Gene Therapy, Precision Biosciences
\n
Date and Time:<\/b> Wednesday, October 25, 2023, 5:00 PM – 6:15 PM CEST and Thursday, October 26, 2023, 8:30 PM – 9:30 PM CEST
\n
Location: <\/b>Gare Maritime<\/p>\n

About Precision BioSciences, Inc.<\/b><\/p>\n

\nPrecision BioSciences, Inc. is an advanced gene editing company dedicated to improving life (DTIL) with its novel and proprietary ARCUS\u00ae<\/sup> genome editing platform that differs from other technologies in the way it cuts, its smaller size, and its simpler structure. ARCUS is a highly precise and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company\u2019s pipeline is comprised of in vivo gene editing candidates designed to deliver lasting cures for the broadest range of genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences, please visit www.precisionbiosciences.com<\/a>.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20231012210195\/en\/<\/a><\/span><\/p>\n

Investor and Media Contact:
\n<\/b>
Mei Burris
\n
Senior Director of Finance and Corporate Controller
\n
Mei.Burris@precisionbiosciences.com<\/a><\/b><\/p>\n

KEYWORDS:<\/b> North Carolina United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Research Infectious Diseases Genetics Clinical Trials Biotechnology General Health Pharmaceutical Health Science Oncology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress DURHAM, N.C.–(BUSINESS WIRE)– Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS\u00ae platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that two abstracts have been accepted by the European Society of Gene & Cell Therapy (ESGCT) for poster presentations at the upcoming Congress on October 24-27, 2023, in Brussels, Belgium. Presentation Details: Title: Unique features of ARCUS nucleases enable high efficiency, targeted gene insertion in vivo Poster Number: #P641 Presenter: Cassie Gorsuch, VP of Gene Therapy, Precision Biosciences Date and Time: Wednesday, October 25, 2023, … <\/p>\n

Continue reading “Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-789927","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPrecision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress DURHAM, N.C.–(BUSINESS WIRE)– Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS\u00ae platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that two abstracts have been accepted by the European Society of Gene & Cell Therapy (ESGCT) for poster presentations at the upcoming Congress on October 24-27, 2023, in Brussels, Belgium. Presentation Details: Title: Unique features of ARCUS nucleases enable high efficiency, targeted gene insertion in vivo Poster Number: #P641 Presenter: Cassie Gorsuch, VP of Gene Therapy, Precision Biosciences Date and Time: Wednesday, October 25, 2023, … Continue reading "Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-12T13:55:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20231012210195r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress\",\"datePublished\":\"2023-10-12T13:55:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/\"},\"wordCount\":373,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20231012210195r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/\",\"name\":\"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20231012210195r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-10-12T13:55:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20231012210195r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20231012210195r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/","og_locale":"en_US","og_type":"article","og_title":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress - Market Newsdesk","og_description":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress DURHAM, N.C.–(BUSINESS WIRE)– Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS\u00ae platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that two abstracts have been accepted by the European Society of Gene & Cell Therapy (ESGCT) for poster presentations at the upcoming Congress on October 24-27, 2023, in Brussels, Belgium. Presentation Details: Title: Unique features of ARCUS nucleases enable high efficiency, targeted gene insertion in vivo Poster Number: #P641 Presenter: Cassie Gorsuch, VP of Gene Therapy, Precision Biosciences Date and Time: Wednesday, October 25, 2023, … Continue reading \"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/","og_site_name":"Market Newsdesk","article_published_time":"2023-10-12T13:55:24+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20231012210195r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress","datePublished":"2023-10-12T13:55:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/"},"wordCount":373,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20231012210195r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/","name":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20231012210195r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-10-12T13:55:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20231012210195r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20231012210195r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/precision-biosciences-to-present-at-the-european-society-of-gene-cell-therapy-esgct-30th-annual-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=789927"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/789927\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=789927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=789927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=789927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}